Competition and pharmaceutical innovation : the moderating role of size and age of leading companies in the market
Year of publication: |
2024
|
---|---|
Authors: | Jung, Ye Lim ; Yoo, Hyoung Sun |
Published in: |
IEEE transactions on engineering management : EM ; a publication of the IEEE Engineering Management Society. - New York, NY : IEEE, ISSN 1558-0040, ZDB-ID 2021741-9. - Vol. 71.2024, p. 3088-3097
|
Subject: | Drug development | innovation activities | market competition | pharmaceutical industry | pharmaceutical innovation | Pharmaindustrie | Pharmaceutical industry | Innovation | Arzneimittel | Pharmaceuticals | Pharmakologie | Pharmacology | Wettbewerb | Competition | Innovationsmanagement | Innovation management | Produktentwicklung | New product development | Arzneimittelmarkt | Pharmaceutical market | Betriebsgröße | Firm size | Generika | Generic drugs |
-
Cahen, Fernanda Ribeiro, (2021)
-
Estimating the cost of strategic entry delay in pharmaceuticals : the case of Ambien CR
Shapiro, Bradley T., (2016)
-
Generic competition and the incentives for early-stage pharmaceutical innovation
Branstetter, Lee, (2022)
- More ...
-
Jung, Ye Lim, (2023)
-
The effect of the commercialization failure of smes’ r&d on survival
Yoo, Hyoung Sun, (2024)
-
Yoo, Hyoung Sun, (2023)
- More ...